|
Market Closed -
NYSE
16:00:02 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 22.11 USD | +0.64% |
|
-3.11% | +24.21% |
| 10-19 | HC Wainwright Adjusts Alto Neuroscience Price Target to $60 From $55, Maintains Buy Rating | MT |
| 10-02 | Alto Neuroscience Insider Sold Shares Worth $3,567,247, According to a Recent SEC Filing | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.64% | -3.11% | -16.53% | -17.44% | +24.21% | +101.00% | - | - | - | 862M | |
| +0.88% | -0.34% | -10.10% | +16.80% | +61.08% | +40.64% | +73.05% | +5.19% | - | 64.69B | |
| -0.26% | +6.91% | -7.69% | -3.01% | +8.84% | +11.14% | +77.36% | +217.41% | +5,594.89% | 54.78B | |
| +0.47% | +3.52% | +11.52% | +15.84% | +18.04% | +8.22% | +100.95% | -15.85% | +260.27% | 53.49B | |
| -2.06% | +2.90% | +1.19% | +31.51% | +21.38% | +24.07% | +48.36% | +6.84% | +274.18% | 45.98B | |
| -1.79% | +0.19% | +2.78% | +13.80% | +22.07% | +19.32% | +123.62% | -3.33% | +1,026.92% | 42.94B | |
| -1.65% | +0.96% | -10.28% | -2.82% | +130.89% | +237.56% | +823.66% | +577.85% | - | 40.08B | |
| -2.26% | -4.14% | +7.10% | +6.98% | +10.22% | +15.38% | +45.53% | +3.86% | +156.29% | 33.52B | |
| -2.57% | -10.53% | -16.14% | +15.83% | +42.43% | +20.12% | -6.22% | -61.89% | - | 23.97B | |
| +12.10% | +16.60% | +30.17% | +57.79% | +46.23% | +55.14% | +46.15% | +0.65% | +168.48% | 23.67B | |
| -1.42% | -2.63% | -11.84% | -2.77% | -8.76% | -17.79% | -10.12% | -70.29% | - | 22.13B | |
| -0.06% | -2.06% | -20.79% | -12.71% | -46.37% | -41.54% | +265.28% | +247.47% | +566.64% | 20.39B | |
| +1.13% | +9.22% | +9.35% | +12.54% | +20.50% | +11.83% | +164.49% | +217.70% | +2,180.99% | 18.72B | |
| +3.45% | +19.08% | +22.00% | +57.68% | +79.10% | +81.32% | +104.07% | -16.88% | +358.10% | 16.49B | |
| +1.51% | +8.92% | +11.14% | +29.49% | +37.79% | +36.65% | +87.98% | -16.17% | +110.17% | 16.47B | |
| +0.90% | +3.88% | +11.95% | +17.59% | +48.55% | +68.16% | +210.20% | +200.60% | +482.38% | 15.99B | |
| +0.73% | +6.61% | +8.67% | -3.43% | - | - | - | - | - | 15.98B | |
| -1.28% | -1.28% | +0.43% | +2.20% | +173.78% | +155.82% | +363.62% | +1,373.64% | +757.63% | 14.75B | |
| -0.80% | +9.30% | +6.64% | +10.87% | +0.86% | +3.18% | -23.60% | -35.55% | +125.72% | 14.29B | |
| -4.33% | -1.79% | +0.97% | -10.50% | +17.19% | +6.98% | +497.27% | - | - | 14.03B | |
| Average | +0.18% | +2.78% | +1.53% | +11.81% | +37.26% | +44.06% | +166.20% | +154.78% | +927.90% | 27.66B | |
| Weighted average by Cap. | -0.02% | +2.49% | +0.61% | +13.16% | +36.88% | +40.92% | +156.92% | +121.32% | +1,257.44% |
- Stock Market
- Stocks
- ANRO Stock
- Sector Alto Neuroscience, Inc.
Select your edition
All financial news and data tailored to specific country editions
